Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 57, 5013-5016, November 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayo, L. D.
Right arrow Articles by Berberich, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayo, L. D.
Right arrow Articles by Berberich, S. J.

Mdm-2 Phosphorylation by DNA-dependent Protein Kinase Prevents Interaction with p531

Lindsey D. Mayo, John J. Turchi and Steven J. Berberich2

Department of Biochemistry and Molecular Biology, Wright State University, Dayton, Ohio 45435

In response to genotoxic stress, the p53 tumor suppressor protein exerts a G1 cell cycle arrest that is dependent on its ability to transactivate downstream target genes. This p53-dependent G1 block is reversed by the binding of Mdm-2 to p53, preventing further transactivation. Interestingly, following DNA damage, the mdm-2 gene is also transcriptionally activated by p53, and therefore, the question of how p53 can continue to transactivate genes in the presence of its own negative regulator has remained unanswered. Here, we provide evidence that phosphorylation of Mdm-2 protein by DNA-dependent protein kinase (DNA-PK) blocks its ability to associate with p53 and regulate p53 transactivation. The data support a model by which DNA-PK activation by DNA damage and phosphorylation of Mdm-2 renders the Mdm-2 protein unable to inhibit p53 transactivation, resulting in cell cycle arrest. Following DNA repair, the loss of DNA-PK activity results in newly synthesized Mdm-2 protein that is unphosphorylated and, therefore, capable of binding to p53, allowing cell cycle progression.

1 This work was supported by NIH Grants CA64374 (to J.J.T.) and CA64430 (to S. J. B.) and by the Ohio Cancer Research Association (to S. J. B.). L. D. M. was supported by a predoctoral fellowship from the Wright State University Biomedical Sciences Program.

2 To whom requests for reprints should be addressed. Phone: (937) 775-4494; Fax: (937) 775-3730; E-mail: sberberich@wright.edu.

Received 8/25/97. Accepted 10/ 3/97.




This article has been cited by other articles:


Home page
Cancer Res.Home page
G. A. LaRusch, M. W. Jackson, J. D. Dunbar, R. S. Warren, D. B. Donner, and L. D. Mayo
Nutlin3 Blocks Vascular Endothelial Growth Factor Induction by Preventing the Interaction between Hypoxia Inducible Factor 1{alpha} and Hdm2
Cancer Res., January 15, 2007; 67(2): 450 - 454.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. J. Cobb, B. Liu, K.-W. Lee, and P. Cohen
Phosphorylation by DNA-Dependent Protein Kinase Is Critical for Apoptosis Induction by Insulin-Like Growth Factor Binding Protein-3.
Cancer Res., November 15, 2006; 66(22): 10878 - 10884.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. T. Patton, L. D. Mayo, A. D. Singhi, A. V. Gudkov, G. R. Stark, and M. W. Jackson
Levels of HdmX Expression Dictate the Sensitivity of Normal and Transformed Cells to Nutlin-3.
Cancer Res., March 15, 2006; 66(6): 3169 - 3176.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
D. Kashatus, P. Cogswell, and A. S. Baldwin
Expression of the Bcl-3 proto-oncogene suppresses p53 activation
Genes & Dev., January 15, 2006; 20(2): 225 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. D. Mayo, Y. R. Seo, M. W. Jackson, M. L. Smith, J. R. Guzman, C. K. Korgaonkar, and D. B. Donner
Phosphorylation of Human p53 at Serine 46 Determines Promoter Selection and whether Apoptosis Is Attenuated or Amplified
J. Biol. Chem., July 15, 2005; 280(28): 25953 - 25959.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. T. Shinohara, L. Geng, J. Tan, H. Chen, Y. Shir, E. Edwards, J. Halbrook, E. A. Kesicki, A. Kashishian, and D. E. Hallahan
DNA-Dependent Protein Kinase Is a Molecular Target for the Development of Noncytotoxic Radiation-Sensitizing Drugs
Cancer Res., June 15, 2005; 65(12): 4987 - 4992.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Deriano, O. Guipaud, H. Merle-Beral, J.-L. Binet, M. Ricoul, G. Potocki-Veronese, V. Favaudon, Z. Maciorowski, C. Muller, B. Salles, et al.
Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway
Blood, June 15, 2005; 105(12): 4776 - 4783.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Daido, A. Yamamoto, K. Fujiwara, R. Sawaya, S. Kondo, and Y. Kondo
Inhibition of the DNA-Dependent Protein Kinase Catalytic Subunit Radiosensitizes Malignant Glioma Cells by Inducing Autophagy
Cancer Res., May 15, 2005; 65(10): 4368 - 4375.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Feng, R. Tamaskovic, Z. Yang, D. P. Brazil, A. Merlo, D. Hess, and B. A. Hemmings
Stabilization of Mdm2 via Decreased Ubiquitination Is Mediated by Protein Kinase B/Akt-dependent Phosphorylation
J. Biol. Chem., August 20, 2004; 279(34): 35510 - 35517.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Boutell and R. D. Everett
Herpes Simplex Virus Type 1 Infection Induces the Stabilization of p53 in a USP7- and ATM-Independent Manner
J. Virol., August 1, 2004; 78(15): 8068 - 8077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. R. Logan, V. Sapountzi, L. Gaughan, D. E. Neal, and C. N. Robson
Control of Human PIRH2 Protein Stability: INVOLVEMENT OF TIP60 AND THE PROTEASOME
J. Biol. Chem., March 19, 2004; 279(12): 11696 - 11704.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. E. Perry
Mdm2 in the Response to Radiation
Mol. Cancer Res., January 1, 2004; 2(1): 9 - 19.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
U. M. Moll and O. Petrenko
The MDM2-p53 Interaction
Mol. Cancer Res., December 1, 2003; 1(14): 1001 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
D. W. Meek and U. Knippschild
Posttranslational Modification of MDM2
Mol. Cancer Res., December 1, 2003; 1(14): 1017 - 1026.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
L. M. Minter, E. S. Dickinson, S. P. Naber, and D. J. Jerry
Epithelial cell cycling predicts p53 responsiveness to {gamma}-irradiation during post-natal mammary gland development
Development, March 8, 2003; 129(12): 2997 - 3008.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. McCoy, J. J. Gesell, M. M. Senior, and D. F. Wyss
Flexible lid to the p53-binding domain of human Mdm2: Implications for p53 regulation
PNAS, February 18, 2003; 100(4): 1645 - 1648.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. P. McKenzie, C. R. McPake, A. A. Ashford, E. F. Vanin, and L. C. Harris
MDM2 Does Not Influence p53-mediated Sensitivity to DNA-damaging Drugs
Mol. Cancer Ther., October 1, 2002; 1(12): 1097 - 1104.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ogawara, S. Kishishita, T. Obata, Y. Isazawa, T. Suzuki, K. Tanaka, N. Masuyama, and Y. Gotoh
Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53
J. Biol. Chem., June 7, 2002; 277(24): 21843 - 21850.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. Alarcon-Vargas and Z.'e. Ronai
p53-Mdm2--the affair that never ends
Carcinogenesis, April 1, 2002; 23(4): 541 - 547.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. D. Mayo and D. B. Donner
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
PNAS, August 10, 2001; (2001) 181181198.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Wang and X. Shi
Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, mdm2 and ERK
Carcinogenesis, May 1, 2001; 22(5): 757 - 762.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R. Maya, M. Balass, S.-T. Kim, D. Shkedy, J.-F. M. Leal, O. Shifman, M. Moas, T. Buschmann, Z.'e. Ronai, Y. Shiloh, et al.
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Genes & Dev., May 1, 2001; 15(9): 1067 - 1077.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
M. S. Rodriguez, J. M. P. Desterro, S. Lain, D. P. Lane, and R. T. Hay
Multiple C-Terminal Lysine Residues Target p53 for Ubiquitin-Proteasome-Mediated Degradation
Mol. Cell. Biol., November 15, 2000; 20(22): 8458 - 8467.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
D. L. Carlisle, D. E. Pritchard, J. Singh, B. M. Owens, L. J. Blankenship, J. M. Orenstein, and S. R. Patierno
Apoptosis and P53 Induction in Human Lung Fibroblasts Exposed to Chromium (VI): Effect of Ascorbate and Tocopherol
Toxicol. Sci., May 1, 2000; 55(1): 60 - 68.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
F. Chen, D. Chang, M. Goh, S. A. Klibanov, and M. Ljungman
Role of p53 in Cell Cycle Regulation and Apoptosis following Exposure to Proteasome Inhibitors
Cell Growth Differ., May 1, 2000; 11(5): 239 - 246.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. Sakaguchi, S.'i. Saito, Y. Higashimoto, S. Roy, C. W. Anderson, and E. Appella
Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like Kinase. EFFECT ON Mdm2 BINDING
J. Biol. Chem., March 24, 2000; 275(13): 9278 - 9283.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
S.-Y. Shieh, J. Ahn, K. Tamai, Y. Taya, and C. Prives
The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites
Genes & Dev., February 1, 2000; 14(3): 289 - 300.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Khosravi, R. Maya, T. Gottlieb, M. Oren, Y. Shiloh, and D. Shkedy
Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage
PNAS, December 21, 1999; 96(26): 14973 - 14977.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Oren
Regulation of the p53 Tumor Suppressor Protein
J. Biol. Chem., December 17, 1999; 274(51): 36031 - 36034.
[Full Text] [PDF]


Home page
J. Virol.Home page
S. E. Seavey, M. Holubar, L. J. Saucedo, and M. E. Perry
The E7 Oncoprotein of Human Papillomavirus Type 16 Stabilizes p53 through a Mechanism Independent of p19ARF
J. Virol., September 1, 1999; 73(9): 7590 - 7598.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. A. Knauf, R. Elisei, D. Mochly-Rosen, T. Liron, X.-N. Chen, R. Gonsky, J. R. Korenberg, and J. A. Fagin
Involvement of Protein Kinase Cepsilon (PKCepsilon ) in Thyroid Cell Death. A TRUNCATED CHIMERIC PKCepsilon CLONED FROM A THYROID CANCER CELL LINE PROTECTS THYROID CELLS FROM APOPTOSIS
J. Biol. Chem., August 13, 1999; 274(33): 23414 - 23425.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. W. Kohn
Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems
Mol. Biol. Cell, August 1, 1999; 10(8): 2703 - 2734.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. A. Kachnic, B. Wu, H. Wunsch, K. L. Mekeel, J. S. DeFrank, W. Tang, and S. N. Powell
The Ability of p53 to Activate Downstream Genes p21WAF1/cip1 and MDM2, and Cell Cycle Arrest following DNA Damage Is Delayed and Attenuated in scid Cells Deficient in the DNA-dependent Protein Kinase
J. Biol. Chem., May 7, 1999; 274(19): 13111 - 13117.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
G. C.M. Smith and S. P. Jackson
The DNA-dependent protein kinase
Genes & Dev., April 15, 1999; 13(8): 916 - 934.
[Full Text]


Home page
CarcinogenesisHome page
U. Stenius, J. Hogberg, and P. Duerksen-Hughes
Re: Yang, J. and Duerksen-Hughes, P. (1998) A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage. Carcinogenesis, 19, 1117–1125.
Carcinogenesis, January 1, 1999; 20(1): 181 - 182.
[Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. H. G. Kubbutat, R. L. Ludwig, M. Ashcroft, and K. H. Vousden
Regulation of Mdm2-Directed Degradation by the C Terminus of p53
Mol. Cell. Biol., October 1, 1998; 18(10): 5690 - 5698.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
A. J. Giaccia and M. B. Kastan
The complexity of p53 modulation: emerging patterns from divergent signals
Genes & Dev., October 1, 1998; 12(19): 2973 - 2983.
[Full Text]


Home page
Genes Dev.Home page
K. Sakaguchi, J. E. Herrera, S.'i. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Anderson, and E. Appella
DNA damage activates p53 through a phosphorylation-acetylation cascade
Genes & Dev., September 15, 1998; 12(18): 2831 - 2841.
[Abstract] [Full Text]


Home page
ScienceHome page
G. Evan and T. Littlewood
A Matter of Life and Cell Death
Science, August 28, 1998; 281(5381): 1317 - 1322.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. O'Neill, A. J. Dwyer, Y. Ziv, D. W. Chan, S. P. Lees-Miller, R. H. Abraham, J. H. Lai, D. Hill, Y. Shiloh, L. C. Cantley, et al.
Utilization of Oriented Peptide Libraries to Identify Substrate Motifs Selected by ATM
J. Biol. Chem., July 21, 2000; 275(30): 22719 - 22727.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. L. Persons, E. M. Yazlovitskaya, and J. C. Pelling
Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to Cisplatin
J. Biol. Chem., November 10, 2000; 275(46): 35778 - 35785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Zhang and C. Prives
Cyclin A-CDK Phosphorylation Regulates MDM2 Protein Interactions
J. Biol. Chem., August 3, 2001; 276(32): 29702 - 29710.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. D. Mayo and D. B. Donner
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
PNAS, September 25, 2001; 98(20): 11598 - 11603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1997 by the American Association for Cancer Research.